Ajanta Pharma Limited (AJANTPHARM.BO)

INR 2884.0

(-0.28%)

Annual Cash Flows

(In INR)
Breakdown 2024 2023 2022 2021 2020 2019
Operating Cash Flow 8.08 Billion 7.91 Billion 5.62 Billion 5.76 Billion 4.56 Billion 3.74 Billion
Net Income 8.16 Billion 7.45 Billion 9.09 Billion 9 Billion 6.63 Billion 5.14 Billion
Depreciation & Amortization 1.35 Billion 1.3 Billion 1.25 Billion 1.16 Billion 957.2 Million 720.8 Million
Deferred income taxes - -1.56 Billion -2.82 Billion -2.39 Billion -1.96 Billion -1.23 Billion
Stock-based compensation 54.9 Million 2.2 Million 3 Million 200 Thousand 4.2 Million 6.7 Million
Change in working capital -997.7 Million 665.2 Million -2 Billion -2.08 Billion -1.23 Billion -903.2 Million
Other non-cash items 3.94 Billion 55.1 Million 102 Million 82.7 Million 158.3 Million 11.6 Million
Investing Cash Flow 383.9 Million -5.59 Billion -741 Million -2.82 Billion -2.24 Billion -2.22 Billion
Investments in PPE -1.52 Billion -1.74 Billion -1.48 Billion -1.71 Billion -2.39 Billion -3.42 Billion
Acquisitions 133.8 Million 183.7 Million 183.8 Million 17.1 Million 54.9 Million 6.3 Million
Investment purchases -20.79 Billion -16.66 Billion -10.62 Billion -7.42 Billion -2.78 Billion -2.74 Billion
Sales/Maturities of investments 22.57 Billion 12.76 Billion 10.91 Billion 6.46 Billion 2.76 Billion 3.92 Billion
Other Investing Activities 267.9 Million -127.7 Million 275.8 Million -162.3 Million 112 Million 17.3 Million
Financing Cash Flow -10.47 Billion -1.07 Billion -4.6 Billion -3.18 Billion -1.28 Billion -1.47 Billion
Debt repayment -600 Thousand -4.9 Million -2.3 Million -440.2 Million -97.3 Million -341.8 Million
Dividends payments -6.42 Billion -896.9 Million -822.1 Million -829 Million -1.15 Billion -791.2 Million
Common Stock Repurchased -3.89 Billion -14.4 Million -2.85 Billion -1.35 Billion - -1 Billion
Common Stock Issuance - 14.4 Million -2.3 Million 440.2 Million - -9.9 Million
Other Financing Activities -9.2 Million -176.9 Million -917.8 Million -999.8 Million -54.6 Million 668.3 Million
Accounts receivables -1.95 Billion -105.5 Million -2.69 Billion 311.3 Million -2.68 Billion -144.3 Million
Accounts payables 408.5 Million 969.1 Million -480.2 Million 111.5 Million 1.32 Billion -243 Million
Inventory -123 Million -223.7 Million -256.6 Million -2.71 Billion -589.3 Million -853.3 Million
Other working capital 671.3 Million 25.3 Million 1.42 Billion 204.2 Million 713.4 Million 337.4 Million
Cash at beginning of period 3.3 Billion 2.06 Billion 1.77 Billion 2.02 Billion 951.6 Million 906.4 Million
Cash at end of period 1.3 Billion 3.3 Billion 2.05 Billion 1.77 Billion 1.98 Billion 951.6 Million
Capital Expenditure -1.52 Billion -1.74 Billion -1.48 Billion -1.71 Billion -2.39 Billion -3.42 Billion
Effect of forex changes on cash - 9.5 Million -4.8 Million 34.6 Million 2.6 Million -2.5 Million
Net cash flow / Change in cash -1.99 Billion 1.24 Billion 279 Million -243.6 Million 1.03 Billion 45.2 Million
Free Cash Flow 6.56 Billion 6.17 Billion 4.13 Billion 4.04 Billion 2.17 Billion 318.1 Million

Cash Flow Charts